Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: Comparative analysis of the Macdonald, RECIST, RANO, and RECIST F criteria

  1. Pérez-Larraya, J.G.
  2. Lahutte, M.
  3. Petrirena, G.
  4. Reyes-Botero, G.
  5. González-Aguilar, A.
  6. Houillier, C.
  7. Guillevin, R.
  8. Sanson, M.
  9. Hoang-Xuan, K.
  10. Delattre, J.-Y.
Revue:
Neuro-Oncology

ISSN: 1522-8517 1523-5866

Année de publication: 2012

Volumen: 14

Número: 5

Pages: 667-673

Type: Article

DOI: 10.1093/NEUONC/NOS070 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable